Posted by Michael Wonder on 02 Feb 2022
ABPI analysis on NICE’s changes for evaluating new medicines: next steps
31 January 2022 - NICE has published a new Manual, which sets out how the latest medicines and health technologies will be evaluated.
The ABPI’s Director of Value and Access Policy, Paul Catchpole, provides further commentary on the publication.
